Evidence map›Paper›PMID 27302108›Full record

ArticleScientific reports2016

Exploring host-pathogen interactions through genome wide protein microarray analysis.

Luigi Scietti, Katia Sampieri, Irene Pinzuti, Erika Bartolini, Barbara Benucci, Alessia Liguori, Andreas F Haag, Paola Lo Surdo, Werner Pansegrau, Vincenzo Nardi-Dei and 17 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Variable disruption of epithelial monolayers byMicrobiology (Reading, England) · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Secretome-Based Screening in Target Discovery.SLAS discovery : advancing life sciences R & D · 2020
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Network Analyses in Plant Pathogens.Frontiers in microbiology · 2018
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 4 institutions in 2 countries.

Luigi SciettiGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Katia SampieriGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Irene PinzutiGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Erika BartoliniGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Barbara BenucciGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Alessia LiguoriGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Andreas F HaagGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Paola Lo SurdoGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Werner PansegrauGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Vincenzo Nardi-DeiGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Laura SantiniGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Seguinde AroraNovartis Institutes for Biomedical Research, Novartis Campus, 4056 Basel, Switzerland.
Xavier LeberNovartis Institutes for Biomedical Research, Novartis Campus, 4056 Basel, Switzerland.
Simonetta RindiDepartment of Molecular Medicine, Unit of Biochemistry, Viale Taramelli 3/b, 27100 Pavia, Italy.
Silvana SavinoGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Paolo CostantinoGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Domenico MaioneGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Marcello MerolaGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Pietro SpezialeDepartment of Molecular Medicine, Unit of Biochemistry, Viale Taramelli 3/b, 27100 Pavia, Italy.
Matthew J BottomleyGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Fabio BagnoliGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Vega MasignaniGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Mariagrazia PizzaGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Meike ScharenbergNovartis Institutes for Biomedical Research, Novartis Campus, 4056 Basel, Switzerland.
Jean-Marc SchlaeppiNovartis Institutes for Biomedical Research, Novartis Campus, 4056 Basel, Switzerland.
Mikkel NissumGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Sabrina LiberatoriGSK Vaccines, Via Fiorentina 1, 53100 Siena, Italy.
Toscana Life Sciences · ITNovartis (Switzerland) · CHUniversity of Pavia · ITNovartis Institutes for BioMedical Research

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During bacterial pathogenesis extensive contacts between the human and the bacterial extracellular proteomes take place. The identification of novel host-pathogen interactions by standard methods using a case-by-case approach is laborious and time consuming. To overcome this limitation, we took advantage of large libraries of human and bacterial recombinant proteins. We applied a large-scale protein microarray-based screening on two important human pathogens using two different approaches: (I) 75 human extracellular proteins were tested on 159 spotted Staphylococcus aureus recombinant proteins and (II) Neisseria meningitidis adhesin (NadA), an important vaccine component against serogroup B meningococcus, was screened against ≈2300 spotted human recombinant proteins. The approach presented here allowed the identification of the interaction between the S. aureus immune evasion protein FLIPr (formyl-peptide receptor like-1 inhibitory protein) and the human complement component C1q, key players of the offense-defense fighting; and of the interaction between meningococcal NadA and human LOX-1 (low-density oxidized lipoprotein receptor), an endothelial receptor. The novel interactions between bacterial and human extracellular proteins here presented might provide a better understanding of the molecular events underlying S. aureus and N. meningitidis pathogenesis.

Indexed as

Host-Pathogen InteractionsAdhesins, BacterialAnimalsBacterial ProteinsBinding SitesCHO CellsComplement C1qCricetulusHumansNeisseria meningitidisProtein Array AnalysisProtein BindingRecombinant ProteinsScavenger Receptors, Class EStaphylococcus aureusAdhesins, BacterialBacterial ProteinsComplement C1qFPRL1 inhibitory protein, S aureusNadA protein, Neisseria meningitidisOLR1 protein, humanRecombinant ProteinsScavenger Receptors, Class E

Identifiers

PMID27302108
PMCPMC4908583
OpenAlexW2440547680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.